STEPHANIE GALLAHER: Open Payments
NPI 1508849290 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$959 in 63 payments from 15 companies in 2025. Trend: 2023 $219 · 2024 $332 · 2025 $959
Food & beverage: $959
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 21 | $226 |
| ABBVIE INC. | 12 | $219 |
| Phathom Pharmaceuticals, Inc. | 10 | $83 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Lilly USA, LLC | 4 | $68 |
| Abbott Laboratories | 1 | $62 |
| Novo Nordisk Inc | 3 | $47 |
| Boston Scientific Corporation | 1 | $39 |
| Edwards Lifesciences Corporation | 1 | $31 |
| Merck Sharp & Dohme LLC | 1 | $24 |
Products named: UBRELVY, NURTEC ODT, VOQUEZNA, QULIPTA, AMPLATZER AMULET, MOUNJARO, ELIQUIS, WATCHMAN FLX.
Industry payments across ID — which companies pay providers there.
